This company listing is no longer active
Resumen de acción 6I7
Labomar S.p.A. researches, develops, manufactures, and sells food supplements, medical devices, cosmetics, and pharmaceutical products in Italy, France, Poland, Spain, North America, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Recompensas
Análisis de riesgos
Competidores de Labomar S.p.A.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | €9.45 |
| 52 Week High | €9.95 |
| 52 Week Low | €7.38 |
| Beta | 0.44 |
| 1 Month Change | 0% |
| 3 Month Change | -3.08% |
| 1 Year Change | 13.58% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 41.68% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| 6I7 | DE Personal Products | Mercado DE | |
|---|---|---|---|
| 7D | 0% | 1.2% | -1.0% |
| 1Y | 13.6% | 0.8% | 2.2% |
Rentabilidad vs. Industria: 6I7 exceeded the German Personal Products industry which returned 12.1% over the past year.
Rentabilidad vs. Mercado: 6I7 exceeded the German Market which returned 9.6% over the past year.
Volatilidad de los precios
| 6I7 volatility | |
|---|---|
| 6I7 Average Weekly Movement | 1.5% |
| Personal Products Industry Average Movement | 4.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.5% |
Precio estable de las acciones: 6I7 has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: 6I7's weekly volatility (1%) has been stable over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1998 | 355 | Walter Bertin | labomar.com |
Resumen de fundamentos de Labomar S.p.A.
| Estadísticas fundamentales de 6I7 | |
|---|---|
| Capitalización bursátil | €183.92m |
| Beneficios(TTM) | €6.14m |
| Ingresos (TTM) | €92.98m |
29.9x
Ratio precio-beneficio (PE)2.0x
Ratio precio-ventas (PS)¿Está 6I7 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de 6I7 | |
|---|---|
| Ingresos | €92.98m |
| Coste de los ingresos | €56.53m |
| Beneficio bruto | €36.44m |
| Otros gastos | €30.30m |
| Beneficios | €6.14m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 0.33 |
| Margen bruto | 39.20% |
| Margen de beneficio neto | 6.61% |
| Ratio deuda/patrimonio | 73.1% |
¿Cómo se ha desempeñado 6I7 a largo plazo?
Ver rendimiento histórico y comparativa